Physician profile
Amit D Alexander Nathani
NPI 1144583428
$519,012.96
in general payments reported to CMS, 2019-2025
26 companies · $52K in 2025
The $52K reported for 2025 was more than what 95% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,899 · 2020: $7,509 · 2021: $45K · 2022: $76K · 2023: $269K · 2024: $67K · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $240K · Consulting Fee: $84K · Education: $21K · Royalty Or License: $19K · Travel and Lodging: $18K · Food and Beverage: $5,880 · Gift: $23.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $240,114.74 |
| Consulting Fee | $84,087.50 |
| Education | $20,625.00 |
| Royalty Or License | $18,862.45 |
| Travel and Lodging | $18,410.64 |
| Food and Beverage | $5,880.08 |
| Gift | $23.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $341,444.54 | 2019-2025 | Tapestry, Juggerknotless Soft Anchor, Tricera Handpiece |
| Embody, INC. | $75,061.27 | 2020-2022 | |
| Maruho Medical, INC. | $49,310.29 | 2020-2022 | |
| Shoulder Innovations, INC. | $27,101.80 | 2021-2025 | Inset System |
| Arthrex, INC. | $13,141.81 | 2023-2025 | Arthrex |
| Medical Device Business Services, INC. | $5,846.84 | 2019-2024 | Inhance |
| Cornerstone Medical Associates, INC. | $2,013.57 | 2023-2024 | |
| Micromed INC | $1,200.00 | 2021 | |
| Stryker Corporation | $1,046.98 | 2020-2025 | Pangea, Profyle, Gamma |
| Depuy Synthes Sales INC. | $967.59 | 2019-2024 | Fibulink, Na |
| Smith+Nephew, INC. | $634.77 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Cpm Medical Consultants, LLC | $227.58 | 2022 | |
| Illuminoss Medical, INC. | $207.79 | 2022-2024 | |
| Globus Medical, INC. | $168.40 | 2022 | |
| Exactech, INC. | $119.89 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $116.15 | 2020-2023 | Maci |
| Nuvasive Specialized Orthopedics, INC. | $115.97 | 2022 | |
| Bioventus LLC | $79.20 | 2019-2025 | L360 Thigh System, Exogen Ultrasound Bone Healing System |
| Abbvie INC. | $55.10 | 2023-2025 | |
| Circinus Medical Technology LLC | $39.87 | 2024 | Bolt Navigation |
| Biodelivery Sciences International, INC. | $27.30 | 2020-2021 | |
| Nevro Corp. | $25.32 | 2021 | |
| Nalu Medical, INC. | $16.50 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.81 | 2025 | Exparel |
| Merck Sharp & Dohme LLC | $15.44 | 2020 | |
| Encore Medical, Lp | $13.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$851,846.61 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Alexander Nathani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.